Meeting
2016 Genitourinary Cancers Symposium
Change in a 17-gene genomic prostate score over time in men with low- and intermediate-risk prostate cancer managed with active surveillance.
Authors
Michael S. Leapman
University of California, San Francisco, San Francisco, CA
Michael S. Leapman , Janet E. Cowan , Hao Gia Nguyen , Matthew R. Cooperberg , Peter Carroll
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 124)
DOI
10.1200/jco.2016.34.2_suppl.124
Abstract #
124
Poster Bd #
F18
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Cribriform pattern, Genomic Prostate Score, and adverse pathology at radical prostatectomy in a cohort of prostate cancer patients initially on active surveillance.
First Author: Kyle Brian Zuniga
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2021 Genitourinary Cancers Symposium
Genomic analysis for active surveillance to predict upstaging after prostatectomy.
First Author: Andrea Quinn
Poster
2018 Genitourinary Cancers Symposium
Validation of a genomic classifier to predict adverse pathology in men diagnosed with low risk prostate cancer.
First Author: Hyung Lae Kim